Table 2.
IgG Antibody | Unadjusted Odds ratio | 95% CI | Adjusted Odds ratio | 95% CI |
---|---|---|---|---|
Age | 1.03 | 1.03–1.04∗∗∗ | 1.01 | 1.00–1.02∗ |
Sex | ||||
F | Reference | Reference | Reference | Reference |
M | 1.04 | 0.8–1.4 | 1.13 | 0.8–1.5 |
Days from onset of symptoms | 1.2 | 1.1–1.2∗∗∗ | 1.1 | 1.07–1.1∗∗∗ |
Clinical Severity | ||||
Mild | Reference | Reference | Reference | Reference |
Moderate | 5.4 | 3.7–7.9∗∗∗ | 2.9 | 2–4.4∗∗∗ |
Severity | 12.7 | 5.9–26.3∗∗∗ | 3.5 | 1.6–7.9∗∗ |
Co-morbidity |
3.1 |
2.4–4∗∗∗ |
1.9 |
1.3–2.6∗∗∗ |
IgM Antibody | ||||
Age | 1.03 | 1.02–1.04∗∗∗ | 1.0 | 0.9–1.01 |
Sex | ||||
F | Reference | Reference | Reference | Reference |
M | 1.3 | 1.01–1.8∗ | 1.5 | 1.1–2.1∗ |
Days from onset of symptoms | 1.1 | 1.07–1.1∗∗∗ | 1.05 | 1.03–1.08∗∗∗ |
Clinical Severity | ||||
Mild | Reference | Reference | Reference | Reference |
Moderate | 5.2 | 3.7–7.4∗∗∗ | 3.3 | 2.3–4.8∗∗∗ |
Severity | 4.6 | 2.8–7.5∗∗∗ | 1.9 | 1.01–3.4∗ |
Co-morbidity | 2.9 | 2.2–3.8∗∗∗ | 2.1 | 1.5–2.9∗∗∗ |
∗<0.05, ∗∗<0.01, ∗∗∗<0.001.